R

Rekah Pharmaceutical Industry Ltd
TASE:REKA

Watchlist Manager
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Watchlist
Price: 1 117 ILS -1.15% Market Closed
Market Cap: 132.2m ILS

Intrinsic Value

The intrinsic value of one REKA stock under the Base Case scenario is hidden ILS. Compared to the current market price of 1 117 ILS, Rekah Pharmaceutical Industry Ltd is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

REKA Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Rekah Pharmaceutical Industry Ltd

Intrinsic Value History
Dive into the past to invest in the future

REKA looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if REKA is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about REKA?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is REKA valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Rekah Pharmaceutical Industry Ltd.

Explain Valuation
Compare REKA to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about REKA?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Rekah Pharmaceutical Industry Ltd

Current Assets 211.4m
Cash & Short-Term Investments 6.1m
Receivables 108.8m
Other Current Assets 96.5m
Non-Current Assets 203.2m
Long-Term Investments 1.2m
PP&E 129.5m
Intangibles 57.2m
Other Non-Current Assets 15.3m
Current Liabilities 128.3m
Accounts Payable 90.9m
Short-Term Debt 24m
Other Current Liabilities 13.4m
Non-Current Liabilities 136m
Long-Term Debt 104.1m
Other Non-Current Liabilities 31.9m
Efficiency

Free Cash Flow Analysis
Rekah Pharmaceutical Industry Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Rekah Pharmaceutical Industry Ltd

Revenue
300.2m ILS
Cost of Revenue
-227.6m ILS
Gross Profit
72.7m ILS
Operating Expenses
-77.1m ILS
Operating Income
-4.4m ILS
Other Expenses
-9.7m ILS
Net Income
-14.1m ILS
Fundamental Scores

REKA Profitability Score
Profitability Due Diligence

Rekah Pharmaceutical Industry Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Healthy Gross Margin
Sustainable 3Y Average Gross Margin
Declining Gross Margin
hidden
Profitability
Score

Rekah Pharmaceutical Industry Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

REKA Solvency Score
Solvency Due Diligence

Rekah Pharmaceutical Industry Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
hidden
Solvency
Score

Rekah Pharmaceutical Industry Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

REKA Price Targets Summary
Rekah Pharmaceutical Industry Ltd

There are no price targets for REKA.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for REKA is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one REKA stock?

The intrinsic value of one REKA stock under the Base Case scenario is hidden ILS.

Is REKA stock undervalued or overvalued?

Compared to the current market price of 1 117 ILS, Rekah Pharmaceutical Industry Ltd is hidden .

Back to Top